This site uses cookies, including third-party cookies, that help us to provide and improve our services. Read More

MRI Safe Implantable Defibrillator Devices Market

MRI Safe Implantable Defibrillator Devices Market

MRI Safe Implantable Defibrillator Devices Market by Product Type (Single Chamber Defibrillator, Dual Chamber Defibrillator), by Modality (MR Conditional Defibrillator, MR Safe Defibrillator), by End User - Global Review 2021 to 2031

MRI Safe Implantable Defibrillator Devices Market


The global demand for MRI safe implantable defribrillator devices witnessed a slight fall in the first quarter of 2020 due to the spread of Covid-19 pandemic. Major attention was shifted towards preventing the ongoing crisis leading to neglecting further developments in this market. However, as the cases are getting down in 2021, incessant efforts of the market players are helping themto recuperate their market position.

In 2021, smart-phone connected heart devices are among the top innovations which is globally attracting the people suffering from cardiac diseases. Pacemakers and other implanted heart devices that can be connected to a patient’s mobile phone is acting as the most impresive breakthrough in healthcare technologies especially in Covid-19 phase for providing mental and physical peace.

Remote monitoring of cardiac patients is a recent trend as it is allowing the heart patients to receive expert medical guidance from their physicians while staying at home or travellinginstead of visiting the hospital premises.

As cyberattacks poses a threat to patient’s data securities, manufacturers in 2020 launched many advanced MRI safe implantable defibrillators with high security controls including access restrictions to protect integrity of device functionalities to create considerable attraction among the users.

At present, smart-innovation is acting as a key factor for promoting the growth of MRI safe implantable defibrillators. Getinge and Boston Corporation are among the market players delivering innovation with their improved outcomes and developments.

The market players in 2021 are focusing more on developing innovative devices to catch global attention. Technological advancements, new product launches, research and develoments, acquisitions, expansions and collaborations continue to be the highly adopted strategies since 2020.

For instance, Boston Corporation launched “DirectSense Technology”, a new tool for monitoring the effect of radiofrequency energy delivery during cardiac ablation procedures on June, 2020. This technology provides data on the impedanceto measure the abilityof tissues to respond to RF energy before physicians deliver therapy. The introduction of this technology has added immense progress to this market by attracting global heart patients towards it.

Further, it has also entered into a definitive agreement to acquire Preventice Solutions, a company that offers a portfolio of mobile cardiac health solutions on 21st January, 2021 with an upfront cash payment of$925 millions and upto an additional $300 million in a potential commercial milestone payment. The portfolio includes BodyGuardian family of remote, wearable cardiac monitorsetc for adult as well as paediatric patients.

In addition to that, Medtronic Corporation on 8th October, 2020 launched “Azure”, a pacemaker that links patient’s smartphones and tablets offering improved longevity so that patients need fewer device replacements and allow them to have MRI (magnetic resonance imaging) scans in either 1.5 or 3 Tesla machines. This pacemaker comes with Bluesync technology that can directly communicate with a patient’s smartphone or tablet.

This latest addition is designed to accurately detect and reduce the likelihood of atrial fabrication and enable automatic and secure wireless communication via bluetooth low energy and remote monitoring through Medtronic CareLink Network, providing more timely alerts of clinically relevant patient events that can be reviewed by a clinician at any time. Security controls are implemented in such devices to protect patient’s data. Azure is becoming the mostly preferred pacemaker in 2021.

Global MRI Safe Implantable Defibrillator Devices Market: Overview

Cardiac defibrillator which were invented to deliver shock in order to control the abnormal heartbeat rhythms were proved to be a valuable device as it can prevent sudden death. MRI which is one of the most important diagnosis test for various problems like neurology, orthopedics, and cardiology found it difficult to test a person implanted with defibrillator as it can cause harm to it, even damaging the myocardium, thus the invention of MRI safe implantable defibrillator devices gained popularity with the healthcare sector with no time.

Flexibility of this defibrillator during MRI test, is the leading factor that is making the people implanted with conventional defibrillator shift to MRI safe implantable defibrillator devices market, as there are certain risk associated with the former during a MRI test.

Factors such as increase in geriatric population, rise in cardiac diseases and product advancement are promoting the growth of MRI safe implantable defibrillator devices. Increase in awareness among patient about their safety and various marketing campaigns by various manufacturers are contributing to the growth of the demand. However, the price tag of these devices is expected to deter the growth of the market during the forecast period. Apart from the price tag, absence of skilled professionals in emerging countries is also anticipated to pull down the market growth.

Cardiac defibrillator is a battery powered pulse generator used to correct the abnormal heart rhythms by delivering an electric shock. It is very valuable device in preventing sudden deaths. For several years in the past, MRI was not allowed in patients having implanted devices such as cardiac defibrillator or pacemakers as it may alter pacing properties or even damage myocardium, thus might be raising concerns for clinicians.

As, MRI is one of the most useful diagnostic test for patients with various medical problems including cardiology, neurology, orthopaedics etc., therefore the development of MRI safe implantable defibrillator devices helps in solving the problem of risks associated with MRI scans. Several research in the area proves that nearly two-third of patients implanted with a defibrillator needed an MRI diagnosis within four years of implantation, thereby generating the need of MRI safe implantable defibrillator devices.

The MRI safe implantable defibrillator devices are available as single chambered or dual chambered. These devices are either recognized as MR conditional or MR safe devices. They contain specific hardware and software components specifically tested and officially verified for use under magnetic resonance environment.

MRI Safe Implantable Defibrillator Devices Market: Drivers & Restraints

Several product advancements, rising geriatric population, increase in cardiac diseases and number of eligible population are some of the factors supporting the market growth of MRI safe implantable defibrillator devices. Furthermore, rising evidence about safety of these systems and effective marketing campaigns by various manufacturers supports the market growth of MRI safe implantable defibrillator devices. However, high product pricing and stringent regulatory issues for product approval lowers its market growth over the forecast period. Reimbursement issues, lack of skilled professionals in several countries are also limiting the market progress.

For more insights, request sample of this report.

MRI Safe Implantable Defibrillator Devices Market: Overview

There are very few companies involved in the manufacturing of devices with MRI compatibility. The products are launched in the market only few years back. Medtronic announced the CE Mark and European launch of first MRI safe implantable defibrillator devices to allow for full-body MRI Scans in April 2014. USFDA has also approved the first MRI compatible ICD manufactured by Medtronic recently in September 2015. Despite the launch of MRI safe implantable defibrillator devices, most of the population is still present with the non-MRI compatible devices.

Companies in this direction are investing on research and development activities for advancement in these device types to improve therapy outcomes and manufacturing of low cost MRI safe implantable defibrillator devices. Top 3 companies in this market represent most of the market share globally for these MRI safe implantable defibrillator devices due to their strong presence, product approvals, brand strength and lack of competitors

Avail customized purchase options for your needs

MRI Safe Implantable Defibrillator Devices Market: Region-wise Outlook

Geographically, North America leads the market for MRI Safe Implantable Defibrillator Devices services owing to the advanced healthcare facilities, high number of implants in the region as well as good reimbursement scenario. This is followed by the Western Europe countries due to easy approval of these devices by CE than by USFDA. Good adoption rate of MRI safe implantable defibrillator devices in the region promotes the growth. APEJ represents a significant growth opportunity for the MRI Safe Implantable Defibrillator devices over the forecast period owing to the rise in cardiac diseases, increase in healthcare spending and rising medical tourism.

Japan also represents a substantial market share over the forecast period owing to the high number of geriatric population as well as available government support for medical facilities. Eastern Europe does not represent a significant market share due to less adoption rate of these devices. Latin America followed by Middle East & Africa represents the least market share as well as growth rate in the MRI Safe Implantable Defibrillator devices over the forecast period but represents a significant market opportunity for the market players because of the number of eligible population in these regions.

MRI Safe Implantable Defibrillator Devices Market Treatment Market: Key Players

Some of the players in the MRI Safe Implantable Defibrillator Devices market includes Medtronic, Boston Scientific Corporation, Abbott, Microport, Biotronik etc.

An Adaptive Approach to Modern-day Research Needs

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size Analysis
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Value Chain Analysis

The regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
  • Eastern Europe (Poland, Russia)
  • Asia-Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • The Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Interested to Procure The Data

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance

For more insights, request sample of this report.

MRI Safe Implantable Defibrillator Devices Market: Segmentation

Segmentation by Product Type:

  • Single Chamber Defibrillator
  • Dual Chamber Defibrillator

Segmentation by Modality:

  • MR Conditional Defibrillator
  • MR Safe Defibrillator

Segmentation by End User

  • Hospitals
  • Ambulatory Surgical Centers

Need an Exclusive Report for your Unique Requirement?

- Related Reports -

Radiopharmaceutical Synthesizer Market

Radiopharmaceutical Synthesizer Market research report covers detailed information on Global Radioph...

Human Growth Hormone (HGH) Market

Human Growth Hormone (HGH) Market research report covers detailed information on Global Human Growth...

MRI Guided Drug Delivery Market

MRI Guided Drug Delivery Market research report Segmented By product type (MRI Guided Drug Delivery ...

Depression Devices Market

Depression Devices Market research report covers detailed information on Global Depression Devices M...

- Our Clients -

Report Client

- Evaluate How Fact.MR's Report Can Help. -

Is the market research conducted by Fact.MR?

Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.

What research methodology is followed by Fact.MR?

Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.

What are the sources of secondary research?

Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.

Who are the respondents for primary research?

Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.

Is a sample of this report available for evaluation?

Yes, you can request a sample, and it will be sent to you through an email.